New positive preclinical data found in conutsion spinal cord injury model

Invivo Therapeutics Holdings Corp., a company who focuses on the development of groundbreaking technologies for treatment of spinal cord injuries (SCI) made a very important announcement today. They have discovered that in a rodent contusion model of SCI the Company’s proprietary bioplymer scaffold showed positive preliminary data that indicate a therapeautic effect.

“We are very excited that results from the most applicable injury model to humans, the contusion model, appear to confirm our findings in the hemisection model,” said Rick Layer, PhD, Research & Development Manager at InVivo Therapeutics.

To learn more, click here.